This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Jennifer Gori
VP, Research at Prime Medicine

Profile

Dr. Jennifer Gori is Vice President, Research, at Prime Medicine. Dr. Gori has 20 years of drug discovery experience, with roles spanning early phase drug discovery research in genome editing and gene and cell therapy to strategic planning and operations for clinical development. Prior to joining Prime Medicine, Dr. Gori led strategic planning and operations and in vivo pharmacology at Obsidian Therapeutics. Prior to Obsidian, Dr. Gori was an early scientist Editas Medicine where she led the preclinical scientific team to discover gene edited cell therapies for clinical development in Hematologic Disease indications. Dr. Gori holds a Ph.D. in Microbiology, Immunology and Cancer Biology from the University of Minnesota.

Agenda Sessions

  • Introduction to Prime Editing, The Search-and-replace Genome Editing Technology

    10:45am